J. M. Armstrong

1.0k total citations · 1 hit paper
36 papers, 840 citations indexed

About

J. M. Armstrong is a scholar working on Molecular Biology, Biochemistry and Physiology. According to data from OpenAlex, J. M. Armstrong has authored 36 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Biochemistry and 11 papers in Physiology. Recurrent topics in J. M. Armstrong's work include Eicosanoids and Hypertension Pharmacology (12 papers), Nitric Oxide and Endothelin Effects (8 papers) and Inflammatory mediators and NSAID effects (8 papers). J. M. Armstrong is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (12 papers), Nitric Oxide and Endothelin Effects (8 papers) and Inflammatory mediators and NSAID effects (8 papers). J. M. Armstrong collaborates with scholars based in United Kingdom, Canada and France. J. M. Armstrong's co-authors include John R. Vane, A.L.A. Boura, Salvador Moncada, Norman Lattimer, R. B. BARLOW, Icilio Cavero, B. Scatton, F Lefèvre-Borg, Kevin Mullane and J C McGiff and has published in prestigious journals such as Nature, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. M. Armstrong

36 papers receiving 725 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F_1α WITH THOSE OF PROSTAGLANDIN E₂ IN RATS AND RABBITS

1978 222 citations J. M. Armstrong, Norman Lattimer et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. M. Armstrong United Kingdom	13	266	251	204	193	174	36	840
Aimée Dallob United States	18	210 0.8×	648 2.6×	173 0.8×	202 1.0×	192 1.1×	27	1.2k
Uffe Bang Olsen Denmark	18	526 2.0×	212 0.8×	106 0.5×	260 1.3×	447 2.6×	50	1.4k
Kouichirou Wada Japan	18	314 1.2×	108 0.4×	163 0.8×	395 2.0×	107 0.6×	33	999
G. Pöch Austria	16	336 1.3×	92 0.4×	59 0.3×	185 1.0×	188 1.1×	45	836
James F. Brien Canada	21	391 1.5×	83 0.3×	224 1.1×	453 2.3×	195 1.1×	55	1.3k
Peter Cervoni United States	18	399 1.5×	88 0.4×	85 0.4×	348 1.8×	178 1.0×	82	1.1k
Jerry G. Webb United States	19	363 1.4×	106 0.4×	45 0.2×	142 0.7×	178 1.0×	57	972
G. P�ch Austria	10	451 1.7×	101 0.4×	60 0.3×	324 1.7×	134 0.8×	15	861
A. Guaitani Italy	18	295 1.1×	79 0.3×	73 0.4×	151 0.8×	131 0.8×	73	1.2k
Inge‐Britt Lindén Finland	15	261 1.0×	125 0.5×	42 0.2×	119 0.6×	175 1.0×	35	1.2k

Countries citing papers authored by J. M. Armstrong

Since Specialization

Citations

This map shows the geographic impact of J. M. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. M. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. M. Armstrong more than expected).

Fields of papers citing papers by J. M. Armstrong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. M. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. M. Armstrong. The network helps show where J. M. Armstrong may publish in the future.

Co-authorship network of co-authors of J. M. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of J. M. Armstrong. A scholar is included among the top collaborators of J. M. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. M. Armstrong. J. M. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lawson, Kim, et al.. (1997). Effects of K⁺channel inhibitors and antagonists on NS‐004 evoked relaxations in guinea‐pig isolated trachea. Fundamental and Clinical Pharmacology. 11(1). 78–82. 2 indexed citations

Alps, B. J., et al.. (1995). Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents. British Journal of Pharmacology. 115(8). 1439–1446. 10 indexed citations

McBean, Douglas E., et al.. (1995). Neuroprotective efficacy of lifarizine (RS‐87476) in a simplified rat survival model of 2 vessel occlusion. British Journal of Pharmacology. 116(8). 3093–3098. 25 indexed citations

Hicks, Peter E., et al.. (1994). An in vitro method for the evaluation of antiarrhythmic and antiischemic agents by using programmed electrical stimulation of rabbit heart. Journal of Pharmacological and Toxicological Methods. 31(1). 31–40. 7 indexed citations

Hicks, Peter E., et al.. (1994). Effects of ATP-dependent K+ channel modulators on an ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation. European Journal of Pharmacology. 256(2). 115–124. 18 indexed citations

Chillon, Jean‐Marc, Isabelle Lartaud, Denis Martin, et al.. (1992). Haemodynamic effects of the calcium facilitator Bay K‐8644 in rats following vascular calcium overload. Journal of Autonomic Pharmacology. 12(5). 311–319. 2 indexed citations

Armstrong, J. M. & Peter E. Hicks. (1992). AN INDUSTRIAL APPROACH TO DRUG DISCOVERY: A PHARMACOLOGIST'S EYEVIEW. Clinical and Experimental Pharmacology and Physiology. 19(1). 51–56. 1 indexed citations

Lawson, Kim, et al.. (1992). Differential effects of endothelin‐1 on the vasorelaxant properties of benzopyran and non‐benzopyran potassium channel openers. British Journal of Pharmacology. 107(1). 58–65. 14 indexed citations

Hicks, Peter E., et al.. (1991). α‐Adrenoceptor subtypes in dog saphenous vein that mediate contraction and inositol phosphate production. British Journal of Pharmacology. 102(1). 151–161. 24 indexed citations

10.

Lawson, Kim, et al.. (1990). BRL-38227, but not RP-49356 or pinacidil, shows higher relaxant potency against low potassium than endothelin-1 contracted rat aorta. European Journal of Pharmacology. 183(2). 266–267. 2 indexed citations

11.

Martin, Denis, et al.. (1990). Pulmonary and systemic haemodynamic effects of cromakalim in conditions of normoxia and hypoxia in dogs. Journal of Autonomic Pharmacology. 10(5). 261–272. 6 indexed citations

12.

Patmore, Leslie, et al.. (1989). Electrophysiologic, Antiarrhythmic, and Cardioprotective Effects of N-[3,5 Dichlorophenyl] 4-[4-Hydroxy-2-Methoxy-Phenyl] Piperazine Carboxamidine Dihydrochloride (RS-87337). Journal of Cardiovascular Pharmacology. 14(2). 184–193. 8 indexed citations

13.

Martin, Denis, et al.. (1989). Pulmonary vascular and renal effects of cromakalim in anaesthetized dogs. Pflügers Archiv - European Journal of Physiology. 414(S1). S192–S193. 4 indexed citations

14.

Armstrong, J. M., et al.. (1983). LY 141865 stimulates histamine-2 (H2) receptors and dopamine-2 (DA2 receptors in the anaesthetised dog. European Journal of Pharmacology. 87(1). 165–166. 25 indexed citations

15.

Armstrong, J. M., F Lefèvre-Borg, B. Scatton, & Icilio Cavero. (1982). Urethane inhibits cardiovascular responses mediated by the stimulation of alpha-2 adrenoceptors in the rat.. Journal of Pharmacology and Experimental Therapeutics. 223(2). 524–535. 75 indexed citations

16.

Armstrong, J. M., A.L.A. Boura, Mats Hámberg, & Bengt Samuelsson. (1976). A comparison of the vasodepressor effects of the cyclic endoperoxides PGG2 and PGH2 with those of PGD2 and PGE2 in hypertensive and normotensive rats. European Journal of Pharmacology. 39(2). 251–258. 43 indexed citations

17.

Armstrong, J. M., Geoffrey J. Blackwell, R.J. Flower, et al.. (1976). Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature. 260(5552). 582–586. 83 indexed citations

18.

Armstrong, J. M. & Norman Lattimer. (1976). Prostaglandin E2 released from the kidneys of genetic hypertensive rats contributes to the vasoconstrictor supersensitivity to angiotensin II in vitro [proceedings].. PubMed. 58(3). 462P–462P. 2 indexed citations

19.

Armstrong, J. M., Geoffrey J. Blackwell, R J Flower, J C McGiff, & Kevin Mullane. (1975). Proceedings: Possible contribution of prostaglandins to genetic hypertension in rats: identification of biochemical lesion.. PubMed. 55(2). 244P–244P. 3 indexed citations

20.

Armstrong, J. M., et al.. (1966). Urinary excretion of silica by grazing sheep. Australian Journal of Agricultural Research. 17(2). 165–173. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact